DCPH - Deciphera Pharmaceuticals EPS misses by $0.09 misses on revenue November, 02 2021 04:12 PM Deciphera Pharmaceuticals Inc. Deciphera Pharmaceuticals (NASDAQ:DCPH): Q3 GAAP EPS of -$1.37 misses by $0.09. Revenue of $23.22M (+50.3% Y/Y) misses by $0.35M. Press Release For further details see: Deciphera Pharmaceuticals EPS misses by $0.09, misses on revenue